Insider Trading29 Jun 2026, 05:41 pm
Fischer Medical Ventures Closes Trading Window for Q1 Results
AI Summary
Fischer Medical Ventures Ltd has announced the closure of its trading window for dealing in the company's equity shares. This closure is in accordance with the company's code of conduct for Prohibition of Insider Trading and SEBI regulations. The window will be shut from July 01, 2026, until 48 hours after the declaration of the Un-Audited Financial Results for the quarter ended June 30, 2026. The company will separately inform stock exchanges about the board meeting to approve these results. Designated persons and their immediate relatives are prohibited from trading during this period.
Key Highlights
- Trading window closed for Q1 FY27 financial results.
- Closure effective from July 01, 2026.
- Prohibits trading by promoters, directors, and designated persons.
- Period extends 48 hours post-results declaration.
- Aims to prevent insider trading as per SEBI regulations.
Price Impact
More from FISCHER